Search
Menu
Alluxa - Optical Coatings LB 8/23

Imaging System Shows Heart Health Risk of Hydroxychloroquine

Facebook X LinkedIn Email
DOUG FARMER, SENIOR EDITOR
[email protected]

An optical mapping system has demonstrated that hydroxychloroquine (HCQ) can cause arrhythmia in animals, so researchers and clinicians are cautious about its effectiveness as a treatment of COVID-19 in people. Previously, HCQ, a less toxic form of chloroquine (CQ), has been prescribed to those with malaria and various autoimmune conditions and has showed some promise in reducing COVID-19 symptoms in a limited number of cases. Images show the voltage surface on a rabbit heart with and without HCQ. Without the drug (normal), the electrical activation spreads homogeneously, while with HCQ,...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: June 2020
    Research & TechnologyOpticsoptical imagingImagingLEDsGeorgia Institute of TechnologyEmory UniversitycoronavirusFiltersheartCOVID-19 News

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.